PGRMC1
Membrane-associated progesterone receptor component 1
Also known as: HPR6.6, PGRC1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00264
- Gene
- PGRMC1
- Ensembl
- ENSG00000101856
- Chromosome
- X
- Canonical length
- 195 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Nucleoli,Endoplasmic reticulum,Mid piece,Principal piece
- Secretome location
- Secreted - unknown location
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a putative membrane-associated progesterone steroid receptor. The protein is expressed predominantly in the liver and kidney. [provided by RefSeq, Mar 2010]
Canonical amino-acid sequenceUniProt
195 residues, UniProt reviewed canonical sequence.
>O00264|PGRMC1
1 MAAEDVVATG ADPSDLESGG LLHEIFTSPL NLLLLGLCIF LLYKIVRGDQ PAASGDSDDD
61 EPPPLPRLKR RDFTPAELRR FDGVQDPRIL MAINGKVFDV TKGRKFYGPE GPYGVFAGRD
121 ASRGLATFCL DKEALKDEYD DLSDLTAAQQ ETLSDWESQF TFKYHHVGKL LKEGEEPTVY
181 SDEEEPKDES ARKNDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PGRMC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 633 nTPM
Expression across tissuesHPA
Tissue
- liver: 633 nTPM
- epididymis: 258 nTPM
- kidney: 220 nTPM
- seminal vesicle: 189 nTPM
- spinal cord: 176 nTPM
- hypothalamus: 173 nTPM
Single-cell type
- platelets: 1,900 nCPM
- hepatocytes: 523 nCPM
- enterocytes: 353 nCPM
- smooth muscle cells: 286 nCPM
- epididymal efferent duct absorptive cells: 280 nCPM
- other brain neurons: 218 nCPM
Immune cell
- total PBMC: 50 nTPM
- basophil: 21 nTPM
- eosinophil: 20 nTPM
- classical monocyte: 20 nTPM
- intermediate monocyte: 20 nTPM
- non-classical monocyte: 19 nTPM
Brain region
- hypothalamus: 181 nTPM
- pons: 180 nTPM
- white matter: 158 nTPM
- midbrain: 143 nTPM
- spinal cord: 135 nTPM
- cerebral cortex: 129 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PGRMC1.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 51 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.82
- gnomAD pLI
- 0.67
- gnomAD missense Z
- 0.08
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- associative learning
- axon guidance
- heme biosynthetic process
- memory
- modification of synaptic structure
- positive regulation of lipoprotein transport
- positive regulation of protein localization to plasma membrane
- negative regulation of synapse organization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PGRMC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PGRMC1 as an antibody target. Whether an autoantibody or antibody against PGRMC1 could matter depends on whether native PGRMC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PGRMC1 is annotated as secreted, so native PGRMC1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PGRMC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...